Group One Trading’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-500
| Closed | -$800 | – | 8102 |
|
|
2025
Q3 | $800 | Hold |
500
| – | – | ﹤0.01% | 8091 |
|
|
2025
Q2 | $700 | Buy |
+500
| New | +$748 | ﹤0.01% | 7618 |
|
|
2024
Q3 | – | Sell |
-12,600
| Closed | -$93.2K | – | 6620 |
|
|
2024
Q2 | $93.2K | Buy |
12,600
+10,000
| +385% | +$82.3K | ﹤0.01% | 4017 |
|
|
2024
Q1 | $20.4K | Buy |
+2,600
| New | +$16.7K | ﹤0.01% | 5400 |
|
|
2023
Q4 | – | Sell |
-5,400
| Closed | -$32K | – | 7357 |
|
|
2023
Q3 | $32K | Sell |
5,400
-25,400
| -82% | -$169K | ﹤0.01% | 5495 |
|
|
2023
Q2 | $229K | Sell |
30,800
-36,100
| -54% | -$307K | ﹤0.01% | 3794 |
|
|
2023
Q1 | $632K | Buy |
66,900
+10,400
| +18% | +$110K | ﹤0.01% | 2543 |
|
|
2022
Q4 | $602K | Buy |
56,500
+38,100
| +207% | +$387K | ﹤0.01% | 2878 |
|
|
2022
Q3 | $136K | Sell |
18,400
-4,400
| -19% | -$27.4K | ﹤0.01% | 4493 |
|
|
2022
Q2 | $110K | Buy |
22,800
+6,000
| +36% | +$34.1K | ﹤0.01% | 4893 |
|
|
2022
Q1 | $86K | Buy |
16,800
+7,800
| +87% | +$41.1K | ﹤0.01% | 5639 |
|
|
2021
Q4 | $54K | Sell |
9,000
-2,400
| -21% | -$18K | ﹤0.01% | 6264 |
|
|
2021
Q3 | $101K | Buy |
11,400
+9,000
| +375% | +$62.6K | ﹤0.01% | 5898 |
|
|
2021
Q2 | $19K | Sell |
2,400
-17,100
| -88% | -$134K | ﹤0.01% | 7208 |
|
|
2021
Q1 | $149K | Sell |
19,500
-75,300
| -79% | -$640K | ﹤0.01% | 5288 |
|
|
2020
Q4 | $739K | Buy |
94,800
+94,400
| +23,600% | +$1.03M | ﹤0.01% | 2918 |
|
|
2020
Q3 | $4K | Buy |
+400
| New | +$4.41K | ﹤0.01% | 5667 |
|
|
2017
Q3 | – | Sell |
-187
| Closed | -$7K | – | 4800 |
|
|
2017
Q2 | $7K | Hold |
187
| – | – | ﹤0.01% | 4316 |
|
|
2017
Q1 | $8K | Buy |
+187
| New | +$7.18K | ﹤0.01% | 4165 |
|
|
2016
Q1 | – | Sell |
-333
| Closed | -$32K | – | 4544 |
|
|
2015
Q4 | $32K | Buy |
333
+313
| +1,565% | +$20.8K | ﹤0.01% | 3666 |
|
|
2015
Q3 | $1K | Sell |
20
-7
| -26% | -$468 | ﹤0.01% | 4748 |
|
|
2015
Q2 | $2K | Sell |
27
-173
| -87% | -$14.8K | ﹤0.01% | 4654 |
|
|
2015
Q1 | $15K | Sell |
200
-60
| -23% | -$7.14K | ﹤0.01% | 4004 |
|
|
2014
Q4 | $46K | Buy |
+260
| New | +$49.4K | ﹤0.01% | 3419 |
|
Other funds holding ATNM
CFM
GS
Group One Trading's ATNM Position: Q4 2025 in Review
Group One Trading sold out of Actinium Pharmaceuticals (ATNM) in Q4 2025, closing a stake of 547 shares — an estimated $798 sold.
Group One Trading first reported a position in ATNM in Q4 2014 and held it in 25 quarters. The position peaked at $533K in Q3 2022. 60 funds tracked by Wall St. Rank hold ATNM as of Q4 2025.
- Group One Trading reported no remaining Actinium Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 547 Actinium Pharmaceuticals shares in Q4 2025, an estimated $798.
- Group One Trading first reported a position in Actinium Pharmaceuticals in Q4 2014 and held it in 25 quarters.
- Group One Trading's Actinium Pharmaceuticals position peaked at $533K in Q3 2022.
- 60 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.